SCHEMBL5589016

SCHEMBL5589016

CCCCOc1cc(OC(=O)O)c(O)c(CCCC)c1CCCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.39
SLC2A1 P11166 1/20 0.39
ALOX5 P09917 2/20 0.38
TP53 P04637 1/20 0.38
S1PR5 Q9H228 2/20 0.37
CYSLTR2 Q9NS75 2/20 0.37
CYSLTR1 Q9Y271 2/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
NFKB1 P19838 1/20 0.37
PPARG P37231 1/20 0.37
BLM P54132 1/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37
GRM2 Q14416 1/20 0.37
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589666 0.96 ALOX5 (0.43) ESR1SLC2A1ALOX5TP53S1PR5
SCHEMBL5587484 0.94 S1PR5 (0.43) ESR1ALOX5S1PR5HPGD
SCHEMBL5588491 0.94 ALOX5 (0.46) ESR1ALOX5TP53S1PR5CYSLTR2
SCHEMBL5587445 0.94 ALOX5 (0.46) ESR1ALOX5TP53S1PR5CYSLTR2
SCHEMBL5590141 0.94 ALOX5 (0.46) ESR1ALOX5TP53S1PR5CYSLTR2
SCHEMBL5587755 0.94 ALOX5 (0.46) ESR1ALOX5TP53S1PR5CYSLTR2
SCHEMBL5589509 0.94 ALOX5 (0.46) ESR1ALOX5TP53S1PR5CYSLTR2
SCHEMBL5586925 0.94 CYSLTR2 (0.42) SLC2A1TP53CYSLTR2CYSLTR1LMNA
SCHEMBL5588157 0.92 ALOX5 (0.46) ESR1ALOX5S1PR5HPGD
SCHEMBL5588327 0.92 ALOX5 (0.46) ESR1ALOX5S1PR5HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ESR1 1108/4885SLC2A1 3915/4885ALOX5 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.